We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Ezcorp Inc
EZPW
$1.8B
| $1.19M | ﹤0.01% |
174,715
+6,328
| +4% | +$36.3K |
|
2002
Metallus
MTUS
$892M
| $1.18M | ﹤0.01% |
150,628
+11,284
| +8% | +$70.7K |
|
|
CRCM
2003
DELISTED
CARE.COM, INC.
CRCM
| $1.18M | ﹤0.01% |
78,805
+5,148
| +7% | +$61.8K |
|
|
AAMI
2004
Acadian Asset Management
AAMI
$3.27B
| $1.18M | ﹤0.01% |
115,756
+434
| +0.4% | +$4.23K |
|
2005
DHT Holdings
DHT
$2.99B
| $1.18M | ﹤0.01% |
142,770
+2,691
| +2% | +$19.9K |
|
2006
Codexis
CDXS
$158M
| $1.18M | ﹤0.01% |
73,747
+4,128
| +6% | +$61.1K |
|
|
JCP
2007
DELISTED
J.C. Penney Company, Inc.
JCP
| $1.17M | ﹤0.01% |
1,039,945
+26,075
| +3% | +$27.7K |
|
2008
Akebia Therapeutics
AKBA
$248M
| $1.16M | ﹤0.01% |
183,902
+6,644
| +4% | +$31.6K |
|
|
RESI
2009
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $1.16M | ﹤0.01% |
94,059
+2,817
| +3% | +$33.5K |
|
2010
Camden National
CAC
$992M
| $1.16M | ﹤0.01% |
25,147
+179
| +0.7% | +$7.9K |
|
2011
Travere Therapeutics
TVTX
$6.07B
| $1.16M | ﹤0.01% |
81,559
+7,734
| +10% | +$98.8K |
|
|
NWLI
2012
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.16M | ﹤0.01% |
3,981
-5
| -0.1% | -$1.34K |
|
2013
Tenable Holdings
TENB
$3.86B
| $1.16M | ﹤0.01% |
48,241
+1,648
| +4% | +$40.1K |
|
2014
Ingles Markets
IMKTA
$1.66B
| $1.15M | ﹤0.01% |
24,287
+629
| +3% | +$26.8K |
|
2015
Horizon Bancorp
HBNC
$1.05B
| $1.15M | ﹤0.01% |
60,572
+464
| +0.8% | +$8.51K |
|
2016
Atara Biotherapeutics
ATRA
$74.1M
| $1.15M | ﹤0.01% |
2,789
+66
| +2% | +$22.8K |
|
2017
International Seaways
INSW
$4.64B
| $1.15M | ﹤0.01% |
38,485
+652
| +2% | +$17K |
|
2018
Origin Bancorp
OBK
$1.67B
| $1.15M | ﹤0.01% |
30,253
+320
| +1% | +$11.2K |
|
|
EVOP
2019
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.14M | ﹤0.01% |
43,274
+2,052
| +5% | +$56.5K |
|
|
TBRG
2020
DELISTED
TruBridge
TBRG
| $1.14M | ﹤0.01% |
43,168
+2,485
| +6% | +$62K |
|
|
GOOD
2021
Gladstone Commercial Corp
GOOD
$631M
| $1.14M | ﹤0.01% |
51,946
+3,498
| +7% | +$79.4K |
|
2022
Cass Information Systems
CASS
$744M
| $1.13M | ﹤0.01% |
19,628
+174
| +0.9% | +$9.74K |
|
|
CIO
2023
DELISTED
City Office REIT
CIO
| $1.13M | ﹤0.01% |
83,675
+17,939
| +27% | +$239K |
|
2024
Donnelley Financial Solutions
DFIN
$1.17B
| $1.13M | ﹤0.01% |
107,801
+2,165
| +2% | +$22.7K |
|
2025
TG Therapeutics
TGTX
$7.67B
| $1.13M | ﹤0.01% |
101,624
+5,945
| +6% | +$45.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.